| 查看: 1714 | 回复: 1 | |||
kobe24song金虫 (正式写手)
|
[交流]
美国明尼苏达大学药物设计中心博后招聘(生物学相关专业)
|
|
A Postdoctoral associate position is immediately available to conduct one or more projects in basic viral replication and antiviral drug discovery for RNA viruses and herpesviruses. Principal Investigator Prof. Robert Geraghty Required qualifications Candidates should have a Ph.D. in biochemistry, cell biology, virology, or related field, a strong background in molecular biology and virology, and have published in international peer-reviewed journals. Preferred qualifications Experience working with recombinant protein expression, cell culture, herpesviruses and in drug discovery is a plus. Duties/responsibilities Identify problems related to the research and recommend solutions as they arise. Familiarity with up-to-date laboratory safety protocols and employ them in the course of all work. Generation of experimental documentation including reporting. Coordinate data collection, analysis and evaluation including reporting. Careful experimentation and record keeping, including the preparation of manuscripts describing the results of the research. Carry out literature searches relative to the research topic Help with the organization and maintenance of the laboratory and its equipment. Participate in research discussions with members of the research teams in a highly collaborative research environment. Other duties as assigned. Interested candidates should submit a pdf with cover letter, CV and names/info for three references to gerag012@umn.edu. |
» 猜你喜欢
关于filecode,很负责任的告诉大家
已经有7人回复
【2027博士申请】纳米药物递送方向
已经有5人回复
关于豆爷回答的JTJC与%2F数量
已经有7人回复
2026国自然放榜时间
已经有3人回复
国基金的申报应该改成非等额制,评价高的钱多评价低的钱少,但是增加资助率
已经有7人回复
好奇怪的filecode
已经有4人回复
售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急
已经有4人回复
售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急
已经有4人回复
售SCI文章,我:8O.5.5.1O.54,科目全,可十急
已经有4人回复
售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急
已经有5人回复
kobe24song
金虫 (正式写手)
- 应助: 1 (幼儿园)
- 金币: 28
- 散金: 1479
- 红花: 4
- 帖子: 493
- 在线: 176.8小时
- 虫号: 1964987
- 注册: 2012-08-30
- 性别: GG
- 专业: 免疫生物学
2楼2018-08-08 22:59:53










回复此楼
20